Medifast (MED) Tops Q2 EPS by 12c

Medifast (NYSE: MED) reported Q2 EPS of $0.63, $0.12 better than the analyst estimate of $0.51. Revenue for the quarter came in at $71.1 million versus the consensus estimate of $72.01 million.

"Our team's efforts to better differentiate our business segments and highlight their respective value propositions helped to fuel solid financial performance in the quarter. In Take Shape For Life, we have built a strong foundation for continued success and are pleased with the double-digit revenue growth in this business unit in the second quarter, which was the highest level of year-over-year growth in three years," said Michael C. MacDonald, Medifast Chairman and Chief Executive Officer. "It's an exciting time for all of us at Medifast, and we believe the company is well positioned for the future as we drive sustainable top and bottom line growth."

For earnings history and earnings-related data on Medifast (MED) click here.

You May Also Be Interested In

• Wolfe Research starts Ferrari at Outperform, sees 'solid upside potential'
• Cal-Maine pays $1.5M in egg price-fixing deal as executives face no charges
• Tradeweb Markets (TW) PT Lowered to $151 at Raymond James